UT Wordmark Primary UT Wordmark Formal Shield Texas UT News Camera Chevron Close Search Copy Link Download File Hamburger Menu Time Stamp Open in browser Load More Pull quote Cloudy and windy Cloudy Partly Cloudy Rain and snow Rain Showers Snow Sunny Thunderstorms Wind and Rain Windy Facebook Instagram LinkedIn Twitter email

UT News

College of Pharmacy Faculty Member Receives $10,000 Award for Outstanding Research

Dr. James McGinity, professor of pharmaceutics in The University of Texas at Austin College of Pharmacy, has received the $10,000 Ralph Shangraw Memorial Award for outstanding research in powder technology and the design and development of novel oral dosage forms.

Two color orange horizontal divider

Dr. James McGinity, professor of pharmaceutics in The University of Texas at Austin College of Pharmacy, has received the $10,000 Ralph Shangraw Memorial Award for outstanding research in powder technology and the design and development of novel oral dosage forms.

The award was presented by the International Pharmaceutical Excipients Council of the Americas Foundation at the annual meeting of the American Association of Pharmaceutical Scientists Nov. 14-18 in New Orleans. Members of the association are dedicated to the discovery, development and manufacture of pharmaceutical products and therapies through advances in science and technology.

Excipients technology is an area of science focusing on the nondrug additives in medications that aid in delivering the drug to the body.

McGinity’s research interests and publications focus on solid dosage forms, film coating of tablets, powder technology, transdermal systems and hot-melt extrusion. Hot-melt extrusion technology has been investigated as a pharmaceutical process to prepare transdermal patches, tablets, granules, pellets and fast-dissolving oral dosage forms.

He is the author or co-author of more than 180 scientific publications and has been issued 23 patents in the areas of materials science, pharmaceutical processing and the design and development of novel drug delivery systems.